NSTG NanoString Technologies

NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and Technology General Meeting in Hollywood, FL. The Company is hosting the Gold Sponsor workshop on Tuesday, February 7th from 12:00-1:30pm EST. This event will also be live-streamed and interested parties can use this to register.

CosMx SMI is a groundbreaking single-cell imaging platform that currently enables high plex imaging of more than 1,000 RNA and over 60 protein analytes within morphologically intact whole tissue sections. During the Gold Sponsor workshop, the Company plans to unveil its innovation roadmap to deliver 6,000-plex RNA and 120-plex protein analytes. This will allow researchers to visualize and quantify gene and protein expression at single cell and subcellular resolutions at unprecedented plex levels, including RNA-plex that is more than 12-times higher than any other commercially available system.

The Gold Sponsor workshop will include presentations by leading academic researchers including:

  • Holger Heyn, PhD, Team Leader of the Centre for Genomics Regulation in Barcelona, Spain, who will be presenting on “Spatial Cellular Maps of Inflammatory Bowel Disease by Single-Molecule Imaging.”
  • Miranda Orr, PhD, Assistant Professor, Wake Forest University School of Medicine, will make a presentation on the “Spatial Functional and Cellular Characterization of Alzheimer’s Disease in Mouse and Human Brain Tissue.”

“We continue to advance the state-of-the-art in single cell imaging, pushing the boundaries of how spatial information can be extracted from a tissue sample,” said Joseph Beechem, PhD, SVP & chief scientific officer of NanoString. “The 1,000-plex RNA panels that we provide today allow CosMx to provide twice as much information per sample as any competing platform, with enough coverage to define both cell types and their activation states. By this time next year, we expect to be commercializing a 6,000-plex RNA panel that will further extend our lead and provide substantial coverage of virtually all the most critical pathways in human biology.”

On Wednesday, February 8 from 7:50 pm – 8:10 pm EST, Dr. Beechem will give a presentation on 6K RNA imaging entitled the ‘Path to the holy grail of spatial biology: spatial single cell whole transcriptomes using ultra-high plex spatial molecular imaging’.

NanoString’s spatial solutions will be represented across 13 accepted abstracts including six presentations by customers. Attendees will also be able to experience product demonstrations for spatial biology solutions including CosMx SMI, GeoMx Digital Spatial Profiler (DSP), and the AtoMx™ Spatial Informatics Portfolio (SIP) in hospitality suite #220 from 9:00am - 5:00pm EST daily throughout all of the conference.

The AtoMx SIP is a flexible cloud-based informatics platform that provides the secure, scalable storage and analysis that spatial biology researchers need to drive their workflow from study design to peer-reviewed publication. The AtoMx SIP is compatible with both the CosMx SMI platform and the GeoMx® Digital Spatial Profiler. A cloud-based platform obviates the need for laboratories to invest in their own costly informatics infrastructure and reduces spatial biology analysis compute times from days to hours. Users have the flexibility to apply a pre-defined data analysis pipeline, to customize these pipelines using their own code, and to access open-source tools developed by the bio-informatics community. The GeoMx DSP is a fully-automated spatial profiler allowing multi-cellular analysis of whole transcriptome for both human and mouse applications, and customizable for other species.

To learn more about NanoString's CosMx Spatial Molecular Imager, visit

About NanoString Technologies, Inc.

NanoString Technologies, a leader in , offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler, cited in more than 190 peer-reviewed publications, is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics from one FFPE slide. The CosMx™ Spatial Molecular Imager is an FFPE-compatible, platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter® Analysis System, cited in more than 6,500 peer-reviewed publications, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. For more information, visit .

NanoString, NanoString Technologies, the NanoString logo, CosMx, GeoMx, AtoMx and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.

EN
06/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NanoString Technologies

 PRESS RELEASE

NanoString Reports Inducement Grants Under Nasdaq Listing Rules

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors approved the grant of, in the aggregate, 34,925 restricted stock units, or RSUs, as material inducements to the 10 employees entering into employment with NanoString. One-third of the R...

 PRESS RELEASE

NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Health...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd annual J.P. Morgan healthcare conference, being held January 8-11, 2024. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, January 10, at 5:15pm ET. Interested parties can access the live webcast from the investor section of the company’s website at . The webcast replay will be available one hour after the conc...

 PRESS RELEASE

NanoString Comments on Delaware District Court Verdict

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx® Digital Spatial Profiler products infringe patents licensed to 10x Genomics and awarding approximately $31 million in damages, consisting of approximately $25 million of lost profits and a $6 million royalty. “We respectfully disagree with the jury’s verdict, which we will seek to have overturned or amend...

 PRESS RELEASE

NanoString to Webcast Presentations from Upcoming Healthcare Conferenc...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. Stifel 2023 Healthcare Conference Tuesday, November 14th Tom Bailey, NanoString’s chief financial officer, and Doug Farrell, VP of Investor Relations, will participate in a fireside discussion hosted by Stifel analyst Dan Arias at 9:45am ET. Jefferies London Healthcare Conference Thursday, November 16th Tom Bailey, Nano...

 PRESS RELEASE

NanoString Technologies Releases Operating Results for Third Quarter o...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023. The Company also announced it had reached agreement with holders to exchange approximately $216 million, or 94%, principal amount of its Convertible Notes for new Senior Secured Notes due September 1, 2026 and common stock warrants. “The last few months have been extraordinarily productive for our team. During the third quarter, we delivered record revenue whi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch